Reliance Capital Valuation
Is 500111 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 500111 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 500111 (₹11.79) is trading below our estimate of fair value (₹1271.14)
Significantly Below Fair Value: 500111 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 500111?
Key metric: As 500111 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 500111's PS Ratio? | |
|---|---|
| PS Ratio | 0.02x |
| Sales | ₹181.81b |
| Market Cap | ₹3.12b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1x |
| Enterprise Value/EBITDA | -16.2x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 500111's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.6x | ||
AMAT Al Madina Insurance Company SAOG | 0.7x | n/a | ر.ع13.7m |
PICO Palestine Insurance | 0.6x | n/a | US$31.5m |
BHASS BH Assurance | 0.7x | 6.1% | د.ت125.7m |
AAME Atlantic American | 0.2x | n/a | US$34.1m |
500111 Reliance Capital | 0.02x | n/a | ₹3.1b |
Price-To-Sales vs Peers: 500111 is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (1.5x).
Price to Sales Ratio vs Industry
How does 500111's PS Ratio compare vs other companies in the Asian Insurance Industry?
Price-To-Sales vs Industry: 500111 is good value based on its Price-To-Sales Ratio (0x) compared to the Asian Insurance industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is 500111's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.02x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 500111's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Star Health and Allied Insurance
₹278.0b
Provides health insurance products in India.
543412
₹474.65
7D
-1.4%
1Y
-12.8%
Star Health and Allied Insurance
₹278.0b
Provides health insurance products in India.
STARHEALTH
₹474.75
7D
-1.4%
1Y
-12.8%
General Insurance Corporation of India
₹621.4b
Provides reinsurance services in India and internationally.
540755
₹354.20
7D
-2.9%
1Y
36.8%